Professional Supplier of Nano-Targeted Drug Scientific Research Products

Liposomes

Fluorescent (NBD lipid (headgroup)) Immunoliposomes-Caproylamine (Non-PEGylated), Lyophilized Powder

Catalog: TASK-25-6000318   CAS NO.: N/A
Delivery Fill in your shipping address to check the estimated shipping fee of your order

Select Shipping Address

$0.00 delivery Normal Delivery(7Days) Details Cyprum itidem insulam procul a continenti

$0.00 delivery Express Delivery Details Cyprum itidem insulam procul a continenti

  • High Quality Products
  • Fast and Safe Delivery

Description

Fluorescent (NBD lipid (headgroup)) Immunoliposomes-Caproylamine (Non-PEGylated), Lyophilized Powder can be designed to cross the blood-liver barrier (BLB) for targeted liver therapies. For instance, liver-targeting drugs or gene-editing tools can be delivered directly to the liver for the treatment of conditions like hepatitis, liver fibrosis, or liver cancer. Beyond, the caproylamine modification can enhance liposomal stability and drug encapsulation, making these liposomes ideal for controlled release of therapeutic agents over extended periods. This allows for the sustained delivery of chemotherapeutics, anti-inflammatory drugs, or hormone therapies, minimizing the need for frequent dosing. The NBD fluorescence can be used to track the progressive release of the drug from the liposome in live cells or animal models, helping optimize drug release profiles for long-term therapeutic applications.

Specifications

CAS No.N/A
Lipid CompositionL-alpha-Phosphatidylcholine/Cholesterol/1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-(hexanoylamine)/1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD on head group)
FormLyophilized Powder
Ship Within1 week
Storage Temp.-20℃
Shipping4-25℃ for up to 3 weeks
Welcome to Taskcm

This email already exists.

Username already exists.

Please confirm the password is the same.

or